[Therapy of acute leukemias in children. 2].
D058186:Acute Kidney Injury / Q000139:chemically induced; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D003630:Daunorubicin / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000209:etiology; D005334:Fever / Q000139:chemically induced; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin
Behandlung der akuten leukämie bei Kindern. 2.